The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029. The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a CAGR of 11.5% during the forecast period of 2024 to 2029. The global market for Gene Synthesis is estimated to increase from $2 billion in 2023 to reach $4.1 billion by 2028, at a CAGR of 15.8% from 2023 through 2028.
One of the major factors in this market's growth is the increasing investment and funding. The rapid growth in research and development of new cell and gene therapies, along with a new level of innovation, also fuels the growth of this market. However, the high cost of developing these therapies restrains the market's growth.
Research Reviews provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of Cell and Gene Therapy provides a sampling of the type of quantitative market information, analysis, and guidance that the analyst has been developing since its inception in 1971 to help its customers make informed business decisions.
Research Review Scope
Cell and gene therapy is a vast industry that uses cells and genes in research, development, manufacture, and distribution to treat diseases. Cells and genes can be utilized in preclinical studies, clinical trials, the production of therapies, viral vectors, modified cells, and personalized medicine.One of the major factors in this market's growth is the increasing investment and funding. The rapid growth in research and development of new cell and gene therapies, along with a new level of innovation, also fuels the growth of this market. However, the high cost of developing these therapies restrains the market's growth.
Research Reviews provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of Cell and Gene Therapy provides a sampling of the type of quantitative market information, analysis, and guidance that the analyst has been developing since its inception in 1971 to help its customers make informed business decisions.
Table of Contents
Chapter 1 Foreword
- Research Review Scope
Chapter 2 Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
- Scope of Report of Cell and Gene Therapy Tools, and Reagents
- Market Summary of Cell and Gene Therapy Tools, and Reagents
- Market Overview of Cell and Gene Therapy Tools, and Reagents
- Approved CGT Products
- Market Dynamics of Cell and Gene Therapy Tools, and Reagents
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Segmentation Analysis of Cell and Gene Therapy Tools, and Reagents
- Segmentation Breakdown of Cell and Gene Therapy Tools, and Reagents
- Global Market for CGT Tools and Reagents, by Product
- Immunoassays
- Bioreactors
- Leukapheresis
- GMP Antibodies
- Multiplex Immunoassays
- Vectors
- Cell Separation
- Cryopreservation
- Cell Expansion
- Media
- GMP Proteins
- GMP Small Molecules
- CRS Monitoring
- Global Market for CGT Tools and Reagents, by Application
- Cancer
- Rare Diseases
- Other Diseases
- Global Market for CGT Tools and Reagents, by End User
- Pharmaceutical and Biotech Companies
- Academic and Research Institutes
- Clinical Laboratories
- Geographic Breakdown
- Global Market for CGT Tools and Reagents, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Emerging Technologies and Developments of Cell and Gene Therapy Tools, and Reagents
- Closed and Automated Systems
- Single-Use Technologies
- Sustainability in the CGT Tool and Reagent Market: ESG Perspective
- Introduction to ESG
- ESG Performance in the Industry
- ESG Practices in the CGT Tool and Reagent Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
Chapter 3 Cell Therapy Biomanufacturing: Global Markets (BIO211B)
- Scope of Report of Cell Therapy Biomanufacturing
- Market Summary of Cell Therapy Biomanufacturing
- Market Overview of Cell Therapy Biomanufacturing
- Overview
- Market Dynamics of Cell Therapy Biomanufacturing
- Overview
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Segmentation Analysis of Cell Therapy Biomanufacturing
- Key Market Trends
- Cell Therapy Biomanufacturing: Global Markets
- Segmentation Breakdown of Cell Therapy Biomanufacturing
- Market Analysis of Cell Therapy Biomanufacturing, by Product Type
- Market Analysis of Cell Therapy Biomanufacturing, by Application
- Skeletal Muscle Repair
- Bone Repair
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Other Diseases
- Geographic Breakdown of Cell Therapy Biomanufacturing
- Market Analysis of Cell Therapy Biomanufacturing, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 4 Gene Synthesis: Technologies and Global Markets (BIO251A)
- Scope of Report of Gene Synthesis
- Market Summary of Gene Synthesis
- Market Overview of Gene Synthesis
- Overview of Gene Synthesis
- Market Dynamics of Gene Synthesis
- Overview
- Market Drivers
- Restraints
- Opportunities
- Challenges
- Segmentation Breakdown of Gene Synthesis
- Gene Synthesis: Global Market
- Global Market for Gene Synthesis, by Method
- Solid-phase Synthesis
- PCR-based Enzyme Synthesis
- Chip-based Synthesis
- Global Market for Gene Synthesis, by Services
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Other Gene Synthesis Services
- Gene Synthesis: Global Markets, by Application
- Gene and Cell Therapy Development
- Vaccine Development
- Disease Diagnosis
- Other Applications
- Global Market for Gene Synthesis, by End User
- Academic and Government Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Geographic Breakdown of Gene Synthesis
- In-house or Outsource?
- Cost Considerations
- Quality Control and Assurance
- Convenience and Turnaround Time
- Customization and Specialization
- Strategic Considerations
- M&A and Venture Funding of Gene Synthesis
- In Summation
Chapter 5 Global Automated and Closed Cell Therapy Market (BIO258A)
- Scope of Report of Automated and Closed Cell Therapy
- Market Insights of Automated and Closed Cell Therapy
- Market Overview of Automated and Closed Cell Therapy
- Overview
- Market Dynamics of Automated and Closed Cell Therapy
- Market Drivers
- Market Restraints
- Market Opportunities
- Segmentation Breakdown of Automated and Closed Cell Therapy
- Global Automated and Closed Cell Therapy Market by Automation Type
- Semi-Automated Cell Therapy
- Fully Automated Cell Therapy
- Global Automated and Closed Cell Therapy Market by Cell Type
- CAR-T Cells
- Stem Cells
- Other Cell Types
- Global Automated and Closed Cell Therapy Market by Application
- Market Size and Forecast
- Clinical
- Commercial
- Geographic Breakdown of Automated and Closed Cell Therapy
- Global Market for Automated and Closed Cell Therapy by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 6 Global Market for Cell and Gene Therapy (BIO225B)
- Scope of Report of Cell and Gene Therapy
- Market Summary of Cell and Gene Therapy
- Market Value of Cell and Gene Therapy
- Market Overview of Cell and Gene Therapy
- Cell and Gene Therapy Overview
- Market Dynamics of Cell and Gene Therapy
- Market Drivers
- Market Restraints
- Market Opportunities
- Segmentation Breakdown of Cell and Gene Therapy
- Global Market for Cell and Gene Therapy
- Market Analysis
- Cell Therapy
- Market Size and Forecast
- Gene-modified Cell Therapy
- Market Size and Forecast
- Gene Therapy
- Market Forecast
- Vectors Used in Gene-modified Cell Therapy and Gene Therapy
- Market Analysis
- Adeno-Associated Viral Vectors
- Retroviral Vectors
- Lentiviral Vectors
- Other Vectors Used in Gene Therapy
- Market Breakdown by Drug Product
- Zolgensma
- Yescarta
- Kymriah
- Abecma
- Maci
- Tecartus
- Epicel
- Other Drug Products
- Market Breakdown by Application
- Oncology
- Rare Diseases
- Ophthalmology
- Other Therapeutic Areas
- Geographic Breakdown of Cell and Gene Therapy
- Market Breakdown of Cell and Gene Therapy by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Global Live Cell Imaging Market (BIO256A)
- Scope of Report of Live Cell Imaging
- Market Summary of Live Cell Imaging
- Market Overview of Live Cell Imaging
- Overview
- Market Dynamics of Live Cell Imaging
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Segmentation Breakdown of Live Cell Imaging
- Market Segmentation of Live Cell Imaging by Components
- Instruments and Software
- Consumables
- Services
- Market Segmentation of Live Cell Imaging, by Technology
- Time-Lapse Microscopy
- Fluorescence Resonance Energy Transfer (FRET)
- Fluorescence Recovery After Photobleaching (FRAP)
- High-Content Screening (HCS)
- Other Technologies
- Market Segmentation of Live Cell Imaging by End User
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Geographic Breakdown of Live Cell Imaging
- North America
- Europe
- Asia-Pacific
- Rest of World
Chapter 8 Global Single-cell Technologies Market (BIO257A)
- Scope of Report of Single-cell Technologies
- Market Summary of Single-cell Technologies
- Market Overview of Single-cell Technologies
- Market Dynamics of Single-cell Technologies
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Segmentation Breakdown of Single-cell Technologies
- Market Analysis of Single-cell Technologies by Product
- Consumables
- Instruments
- Market Breakdown of Single-cell Technologies by Cell Type
- Human Cells
- Animal Cells
- Microbial Cells
- Market Breakdown by Technique
- Flow Cytometry
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Other Techniques
- Market Breakdown of Single-cell Technologies by Application
- Research Applications
- Medical Applications
- Market Breakdown of Single-cell Technologies by End User
- Research and Academic Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Cell Banks and IVF Centers
- Geographic Breakdown of Single-cell Technologies
- Market Analysis by Region of Single-cell Technologies
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 9 Appendix
- Methodology
- Analyst's Credentials
List of Tables
Table 1: Global Market for CGT Tools and Reagents, by Application, Through 2029
Table 2: Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 3: Approved CGT Products, as of 2024
Table 4: Global Cancer Statistics, 2022
Table 5: Global Market for CGT Tools and Reagents, by Product, Through 2029
Table 6: Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
Table 7: Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
Table 8: Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
Table 9: Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
Table 10: Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
Table 11: Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
Table 12: Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
Table 13: Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
Table 14: Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
Table 15: Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
Table 16: Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
Table 17: Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
Table 18: Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
Table 19: Global Market for CGT Tools and Reagents, by Application, Through 2029
Table 20: Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
Table 21: Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
Table 22: Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
Table 23: Global Market for CGT Tools and Reagents, by End User, Through 2029
Table 24: Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
Table 25: Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
Table 26: Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
Table 27: Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 28: North American Market for CGT Tools and Reagents, by Product, Through 2029
Table 29: North American Market for CGT Tools and Reagents, by Application, Through 2029
Table 30: North American Market for CGT Tools and Reagents, by End User, Through 2029
Table 31: European Research Initiatives Focused on Personalized Medicine
Table 32: European Market for CGT Tools and Reagents, by Product, Through 2029
Table 33: European Market for CGT Tools and Reagents, by Application, Through 2029
Table 34: European Market for CGT Tools and Reagents, by End User, Through 2029
Table 35: Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
Table 36: Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
Table 37: Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
Table 38: RoW Market for CGT Tools and Reagents, by Product, Through 2029
Table 39: RoW Market for CGT Tools and Reagents, by Application, Through 2029
Table 40: RoW Market for CGT Tools and Reagents, by End User, Through 2029
Table 41: Focus Areas in ESG Metrics
Table 42: Environmental Performance Initiatives in the CGT Tool and Reagent Market
Table 43: Social Performance Initiatives in the CGT Tool and Reagent Market
Table 44: Governance Performance Initiatives in the CGT Tool and Reagent Market
Table 45: ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
Table 46: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Table 47: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 48: Global Market for Cell Therapy Biomanufacturing, Through 2029
Table 49: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Table 50: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 51: Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
Table 52: North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 53: European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 54: Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 55: Global Market for Gene Synthesis, Through 2028
Table 56: Global Market for Gene Synthesis, by Services, Through 2028
Table 57: Global Market for Gene Synthesis, Through 2028
Table 58: Global Market for Gene Synthesis, by Method, Through 2028
Table 59: Global Market for Solid-phase Synthesis, by Region, Through 2028
Table 60: Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
Table 61: Global Market for Chip-based Synthesis, by Region, Through 2028
Table 62: Global Market for Gene Synthesis, by Services, Through 2028
Table 63: Global Market for Antibody DNA Synthesis, by Region, Through 2028
Table 64: Global Market for Viral DNA Synthesis, by Region, Through 2028
Table 65: Global Market for Other Synthesis Services, by Region, Through 2028
Table 66: Global Market for Gene Synthesis, by Application, Through 2028
Table 67: Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
Table 68: Global Market for Vaccine Development Applications, by Region, Through 2028
Table 69: Global Market for Disease Diagnosis Applications, by Region, Through 2028
Table 70: Global Market for Other Applications, by Region, Through 2028
Table 71: Global Market for Gene Synthesis, by End User, Through 2028
Table 72: Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
Table 73: Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
Table 74: Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
Table 75: Mergers and Acquisitions (M&A), 2021-2023
Table 76: Venture Funding, 2022 and 2023
Table 77: Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
Table 78: Differences between Semi-Automation and Full Automation in Cell Therapy
Table 79: Global Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 80: Select Semi-Automated Cell Therapy Systems
Table 81: Global Market for Semi-Automated Cell Therapy, by Region, Through 2029
Table 82: Global Market for Semi-Automated Cell Therapy, by Workflow, Through 2029
Table 83: Global Market for Automated and Closed Apheresis, by Region, Through 2029
Table 84: Global Market for Automated and Closed Expansion, by Region, Through 2029
Table 85: Global Market for Automated and Closed Fill-Finish, by Region, Through 2029
Table 86: Global Market for Automated and Closed Separation, by Region, Through 2029
Table 87: Global Market for Other Automated and Closed Workflows, by Region, Through 2029
Table 88: Global Market for Fully Automated Cell Therapy, by Region, Through 2029
Table 89: Global Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 90: FDA-Approved CAR-T Cell Therapies
Table 91: Global Market for Automated and Closed CAR-T Cell Therapy, by Region, Through 2029
Table 92: Global Market for Automated and Closed Stem Cell Therapy, by Region, Through 2029
Table 93: Global Market for Automated and Closed Other Cell Therapies, by Region, Through 2029
Table 94: Global Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 95: Global Market for Clinical Automated and Closed Cell Therapy, by Region, Through 2029
Table 96: Global Market for Commercial Automated and Closed Cell Therapy, by Region, Through 2029
Table 97: Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
Table 98: North American Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 99: North American Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 100: North American Market for Semi-automated Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 101: North American Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 102: North American Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 103: European Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 104: European Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 105: European Market for Semi-Automated Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 106: European Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 107: European Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 108: Asia-Pacific Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 109: Asia-Pacific Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 110: Asia-Pacific Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 111: Asia-Pacific Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 112: Asia-Pacific Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 113: RoW Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 114: RoW Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 115: RoW Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 116: RoW Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 117: Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
Table 118: Number of New Cases and Deaths Due to Various Cancers Globally, 2020
Table 119: Comparison of Accelerated Approvals for Various Drugs
Table 120: Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
Table 121: Global Market for Cell Therapy, by Region, Through 2028
Table 122: Approved CAR-T Products, as of December 2023
Table 123: Global Market for Gene-modified Cell Therapy, by Region, Through 2028
Table 124: Global Market for Gene Therapy, by Region, Through 2028
Table 125: Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, Through 2028
Table 126: Global Market for Cell and Gene Therapy, by Drug Product, Through 2028
Table 127: Global Market for Cell and Gene Therapy, by Application, Through 2028
Table 128: Global Market for Cell and Gene Therapy for Oncology, by Region, Through 2028
Table 129: Global Market for Cell and Gene Therapy for Rare Diseases, by Region, Through 2028
Table 130: Global Market for Cell and Gene Therapy for Ophthalmology, by Region, Through 2028
Table 131: Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, Through 2028
Table 132: Global Market for Cell and Gene Therapy, by Region, Through 2028
Table 133: North American Market for Cell and Gene Therapy, by Country, Through 2028
Table 134: European Market for Cell and Gene Therapy, by Country, Through 2028
Table 135: Asia-Pacific Market for Cell and Gene Therapy, by Country, Through 2028
Table 136: Global Market for Live Cell Imaging, by Region, Through 2029
Table 137: Global Market for Live Cell Imaging, by Components, Through 2029
Table 138: Global Market for Live Cell Imaging Instruments and Software, by Region, Through 2029
Table 139: Global Market for Live Cell Imaging Consumables, by Region, Through 2029
Table 140: Global Market for Live Cell Imaging Services, by Region, Through 2029
Table 141: Global Market for Live Cell Imaging, by Technology, Through 2029
Table 142: Global Market for Time-Lapse Microscopy, by Region, Through 2029
Table 143: Global Market for Fluorescence Resonance Energy Transfer, by Region, Through 2029
Table 144: Global Market for Fluorescence Recovery After Photobleaching, by Region, Through 2029
Table 145: Global Market for High-Content Screening, by Region, Through 2029
Table 146: Global Market for Other Technologies in Live Cell Imaging, by Region, Through 2029
Table 147: Global Market for Live Cell Imaging, by End User, Through 2029
Table 148: Global Market for Pharmaceutical and Biotechnology Companies Using Live Cell Imaging, by Region, Through 2029
Table 149: A Few Academic Research Institute Using Live Cell Imaging Research
Table 150: Global Market for Academic Research Institutes Using Live Cell Imaging, by Region, Through 2029
Table 151: A Few Contract Research Organizations Using Live Cell Imaging
Table 152: Global Market for Contract Research Organizations Using Live Cell Imaging, by Region, Through 2029
Table 153: Global Market for Live Cell Imaging, by Region, Through 2029
Table 154: North American Market for Live Cell Imaging, by Country, Through 2029
Table 155: North American Market for Live Cell Imaging, by Components, Through 2029
Table 156: North American Market for Live Cell Imaging, by Technology, Through 2029
Table 157: North American Market for Live Cell Imaging, by End User, Through 2029
Table 158: U.S. Market for Live Cell Imaging, Through 2029
Table 159: Canadian Market for Live Cell Imaging, Through 2029
Table 160: Mexican Market for Live Cell Imaging, Through 2029
Table 161: European Market for Live Cell Imaging, by Country, Through 2029
Table 162: European Market for Live Cell Imaging, by Components, Through 2029
Table 163: European Market for Live Cell Imaging, by Technology, Through 2029
Table 164: European Market for Live Cell Imaging, by End User, Through 2029
Table 165: German Market for Live Cell Imaging, Through 2029
Table 166: U.K. Market for Live Cell Imaging, Through 2029
Table 167: French Market for Live Cell Imaging, Through 2029
Table 168: Spanish Market for Live Cell Imaging, Through 2029
Table 169: Italian Market for Live Cell Imaging, Through 2029
Table 170: Rest of European Market for Live Cell Imaging, Through 2029
Table 171: Asia-Pacific Market for Live Cell Imaging, by Country, Through 2029
Table 172: Asia-Pacific Market for Live Cell Imaging, by Components, Through 2029
Table 173: Asia-Pacific Market for Live Cell Imaging, by Technology, Through 2029
Table 174: Asia-Pacific Market for Live Cell Imaging, by End User, Through 2029
Table 175: Chinese Market for Live Cell Imaging, Through 2029
Table 176: Japanese Market for Live Cell Imaging, Through 2029
Table 177: Indian Market for Live Cell Imaging, Through 2029
Table 178: South Korean Market for Live Cell Imaging, Through 2029
Table 179: Rest of Asia-Pacific Market for Live Cell Imaging, Through 2029
Table 180: Rest of the World Market for Live Cell Imaging, by Components, Through 2029
Table 181: Rest of the World Market for Live Cell Imaging, by Technology, Through 2029
Table 182: Rest of the World Market for Live Cell Imaging, by End User, Through 2029
Table 183: Global Market for Single-Cell Technologies, by Product, Through 2029
Table 184: Assay Kits Offered by 10X Genomics
Table 185: Global Market for Single-Cell Technologies Consumables, by Region, Through 2029
Table 186: Single-Cell Technologies Flow Cytometry Systems, by Company
Table 187: Single-Cell Technologies NGS Systems, by Company
Table 188: Single-Cell Technologies PCR Systems, by Company
Table 189: Single-Cell Technologies Mass Spectrophotometers, by Company
Table 190: Single-Cell Technologies Microscopes, by Company
Table 191: Global Market for Single-Cell Technologies Instruments, by Region, Through 2029
Table 192: Global Market for Single-Cell Technologies, by Cell Type, Through 2029
Table 193: Global Market for Single-Cell Technologies in the Human Cells Segment, by Region, Through 2029
Table 194: Global Market for Single-Cell Technologies in the Animal Cells Segment, by Region, Through 2029
Table 195: Global Market for Single-Cell Technologies in the Microbial Cells Segment, by Region, Through 2029
Table 196: Global Market for Single-Cell Technologies, by Technique, Through 2029
Table 197: Global Market for Flow Cytometry in Single-Cell Technologies, by Region, Through 2029
Table 198: Global Market for Next-Generation Sequencing in Single-Cell Technologies, by Region, Through 2029
Table 199: Global Market for Polymerase Chain Reaction in Single-Cell Technologies, by Region, Through 2029
Table 200: Global Market for Microscopy in Single-Cell Technologies, by Region, Through 2029
Table 201: Global Market for Mass Spectrometry in Single-Cell Technologies, by Region, Through 2029
Table 202: Global Market for Other Techniques in Single-Cell Technologies, by Region, Through 2029
Table 203: Global Market for Single-Cell Technologies, by Application, Through 2029
Table 204: Global Market for Research Applications in Single-Cell Technologies, by Region, Through 2029
Table 205: Global Market for Medical Applications of Single-Cell Technologies, by Region, Through 2029
Table 206: Global Market for Single-Cell Technologies, by End User, Through 2029
Table 207: Global Market for Single-Cell Technologies in Research and Academic Laboratories, by Region, Through 2029
Table 208: Global Market for Single-Cell Technologies in Biotechnology and Pharmaceutical Companies, by Region, Through 2029
Table 209: Global Market for Single-Cell Technologies in Hospitals and Diagnostic Laboratories, by Region, Through 2029
Table 210: Stem Cell Banks and Registries Worldwide, by Country
Table 211: Global Market for Single-Cell Technologies in Cell Banks and IVF Centers, by Region, Through 2029
Table 212: Global Market for Single-Cell Technologies, by Region, Through 2029
Table 2: Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 3: Approved CGT Products, as of 2024
Table 4: Global Cancer Statistics, 2022
Table 5: Global Market for CGT Tools and Reagents, by Product, Through 2029
Table 6: Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
Table 7: Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
Table 8: Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
Table 9: Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
Table 10: Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
Table 11: Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
Table 12: Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
Table 13: Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
Table 14: Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
Table 15: Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
Table 16: Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
Table 17: Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
Table 18: Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
Table 19: Global Market for CGT Tools and Reagents, by Application, Through 2029
Table 20: Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
Table 21: Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
Table 22: Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
Table 23: Global Market for CGT Tools and Reagents, by End User, Through 2029
Table 24: Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
Table 25: Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
Table 26: Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
Table 27: Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 28: North American Market for CGT Tools and Reagents, by Product, Through 2029
Table 29: North American Market for CGT Tools and Reagents, by Application, Through 2029
Table 30: North American Market for CGT Tools and Reagents, by End User, Through 2029
Table 31: European Research Initiatives Focused on Personalized Medicine
Table 32: European Market for CGT Tools and Reagents, by Product, Through 2029
Table 33: European Market for CGT Tools and Reagents, by Application, Through 2029
Table 34: European Market for CGT Tools and Reagents, by End User, Through 2029
Table 35: Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
Table 36: Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
Table 37: Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
Table 38: RoW Market for CGT Tools and Reagents, by Product, Through 2029
Table 39: RoW Market for CGT Tools and Reagents, by Application, Through 2029
Table 40: RoW Market for CGT Tools and Reagents, by End User, Through 2029
Table 41: Focus Areas in ESG Metrics
Table 42: Environmental Performance Initiatives in the CGT Tool and Reagent Market
Table 43: Social Performance Initiatives in the CGT Tool and Reagent Market
Table 44: Governance Performance Initiatives in the CGT Tool and Reagent Market
Table 45: ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
Table 46: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Table 47: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 48: Global Market for Cell Therapy Biomanufacturing, Through 2029
Table 49: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Table 50: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 51: Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
Table 52: North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 53: European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 54: Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 55: Global Market for Gene Synthesis, Through 2028
Table 56: Global Market for Gene Synthesis, by Services, Through 2028
Table 57: Global Market for Gene Synthesis, Through 2028
Table 58: Global Market for Gene Synthesis, by Method, Through 2028
Table 59: Global Market for Solid-phase Synthesis, by Region, Through 2028
Table 60: Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
Table 61: Global Market for Chip-based Synthesis, by Region, Through 2028
Table 62: Global Market for Gene Synthesis, by Services, Through 2028
Table 63: Global Market for Antibody DNA Synthesis, by Region, Through 2028
Table 64: Global Market for Viral DNA Synthesis, by Region, Through 2028
Table 65: Global Market for Other Synthesis Services, by Region, Through 2028
Table 66: Global Market for Gene Synthesis, by Application, Through 2028
Table 67: Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
Table 68: Global Market for Vaccine Development Applications, by Region, Through 2028
Table 69: Global Market for Disease Diagnosis Applications, by Region, Through 2028
Table 70: Global Market for Other Applications, by Region, Through 2028
Table 71: Global Market for Gene Synthesis, by End User, Through 2028
Table 72: Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
Table 73: Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
Table 74: Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
Table 75: Mergers and Acquisitions (M&A), 2021-2023
Table 76: Venture Funding, 2022 and 2023
Table 77: Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
Table 78: Differences between Semi-Automation and Full Automation in Cell Therapy
Table 79: Global Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 80: Select Semi-Automated Cell Therapy Systems
Table 81: Global Market for Semi-Automated Cell Therapy, by Region, Through 2029
Table 82: Global Market for Semi-Automated Cell Therapy, by Workflow, Through 2029
Table 83: Global Market for Automated and Closed Apheresis, by Region, Through 2029
Table 84: Global Market for Automated and Closed Expansion, by Region, Through 2029
Table 85: Global Market for Automated and Closed Fill-Finish, by Region, Through 2029
Table 86: Global Market for Automated and Closed Separation, by Region, Through 2029
Table 87: Global Market for Other Automated and Closed Workflows, by Region, Through 2029
Table 88: Global Market for Fully Automated Cell Therapy, by Region, Through 2029
Table 89: Global Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 90: FDA-Approved CAR-T Cell Therapies
Table 91: Global Market for Automated and Closed CAR-T Cell Therapy, by Region, Through 2029
Table 92: Global Market for Automated and Closed Stem Cell Therapy, by Region, Through 2029
Table 93: Global Market for Automated and Closed Other Cell Therapies, by Region, Through 2029
Table 94: Global Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 95: Global Market for Clinical Automated and Closed Cell Therapy, by Region, Through 2029
Table 96: Global Market for Commercial Automated and Closed Cell Therapy, by Region, Through 2029
Table 97: Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
Table 98: North American Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 99: North American Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 100: North American Market for Semi-automated Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 101: North American Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 102: North American Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 103: European Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 104: European Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 105: European Market for Semi-Automated Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 106: European Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 107: European Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 108: Asia-Pacific Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 109: Asia-Pacific Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 110: Asia-Pacific Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 111: Asia-Pacific Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 112: Asia-Pacific Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 113: RoW Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 114: RoW Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 115: RoW Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 116: RoW Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 117: Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
Table 118: Number of New Cases and Deaths Due to Various Cancers Globally, 2020
Table 119: Comparison of Accelerated Approvals for Various Drugs
Table 120: Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
Table 121: Global Market for Cell Therapy, by Region, Through 2028
Table 122: Approved CAR-T Products, as of December 2023
Table 123: Global Market for Gene-modified Cell Therapy, by Region, Through 2028
Table 124: Global Market for Gene Therapy, by Region, Through 2028
Table 125: Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, Through 2028
Table 126: Global Market for Cell and Gene Therapy, by Drug Product, Through 2028
Table 127: Global Market for Cell and Gene Therapy, by Application, Through 2028
Table 128: Global Market for Cell and Gene Therapy for Oncology, by Region, Through 2028
Table 129: Global Market for Cell and Gene Therapy for Rare Diseases, by Region, Through 2028
Table 130: Global Market for Cell and Gene Therapy for Ophthalmology, by Region, Through 2028
Table 131: Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, Through 2028
Table 132: Global Market for Cell and Gene Therapy, by Region, Through 2028
Table 133: North American Market for Cell and Gene Therapy, by Country, Through 2028
Table 134: European Market for Cell and Gene Therapy, by Country, Through 2028
Table 135: Asia-Pacific Market for Cell and Gene Therapy, by Country, Through 2028
Table 136: Global Market for Live Cell Imaging, by Region, Through 2029
Table 137: Global Market for Live Cell Imaging, by Components, Through 2029
Table 138: Global Market for Live Cell Imaging Instruments and Software, by Region, Through 2029
Table 139: Global Market for Live Cell Imaging Consumables, by Region, Through 2029
Table 140: Global Market for Live Cell Imaging Services, by Region, Through 2029
Table 141: Global Market for Live Cell Imaging, by Technology, Through 2029
Table 142: Global Market for Time-Lapse Microscopy, by Region, Through 2029
Table 143: Global Market for Fluorescence Resonance Energy Transfer, by Region, Through 2029
Table 144: Global Market for Fluorescence Recovery After Photobleaching, by Region, Through 2029
Table 145: Global Market for High-Content Screening, by Region, Through 2029
Table 146: Global Market for Other Technologies in Live Cell Imaging, by Region, Through 2029
Table 147: Global Market for Live Cell Imaging, by End User, Through 2029
Table 148: Global Market for Pharmaceutical and Biotechnology Companies Using Live Cell Imaging, by Region, Through 2029
Table 149: A Few Academic Research Institute Using Live Cell Imaging Research
Table 150: Global Market for Academic Research Institutes Using Live Cell Imaging, by Region, Through 2029
Table 151: A Few Contract Research Organizations Using Live Cell Imaging
Table 152: Global Market for Contract Research Organizations Using Live Cell Imaging, by Region, Through 2029
Table 153: Global Market for Live Cell Imaging, by Region, Through 2029
Table 154: North American Market for Live Cell Imaging, by Country, Through 2029
Table 155: North American Market for Live Cell Imaging, by Components, Through 2029
Table 156: North American Market for Live Cell Imaging, by Technology, Through 2029
Table 157: North American Market for Live Cell Imaging, by End User, Through 2029
Table 158: U.S. Market for Live Cell Imaging, Through 2029
Table 159: Canadian Market for Live Cell Imaging, Through 2029
Table 160: Mexican Market for Live Cell Imaging, Through 2029
Table 161: European Market for Live Cell Imaging, by Country, Through 2029
Table 162: European Market for Live Cell Imaging, by Components, Through 2029
Table 163: European Market for Live Cell Imaging, by Technology, Through 2029
Table 164: European Market for Live Cell Imaging, by End User, Through 2029
Table 165: German Market for Live Cell Imaging, Through 2029
Table 166: U.K. Market for Live Cell Imaging, Through 2029
Table 167: French Market for Live Cell Imaging, Through 2029
Table 168: Spanish Market for Live Cell Imaging, Through 2029
Table 169: Italian Market for Live Cell Imaging, Through 2029
Table 170: Rest of European Market for Live Cell Imaging, Through 2029
Table 171: Asia-Pacific Market for Live Cell Imaging, by Country, Through 2029
Table 172: Asia-Pacific Market for Live Cell Imaging, by Components, Through 2029
Table 173: Asia-Pacific Market for Live Cell Imaging, by Technology, Through 2029
Table 174: Asia-Pacific Market for Live Cell Imaging, by End User, Through 2029
Table 175: Chinese Market for Live Cell Imaging, Through 2029
Table 176: Japanese Market for Live Cell Imaging, Through 2029
Table 177: Indian Market for Live Cell Imaging, Through 2029
Table 178: South Korean Market for Live Cell Imaging, Through 2029
Table 179: Rest of Asia-Pacific Market for Live Cell Imaging, Through 2029
Table 180: Rest of the World Market for Live Cell Imaging, by Components, Through 2029
Table 181: Rest of the World Market for Live Cell Imaging, by Technology, Through 2029
Table 182: Rest of the World Market for Live Cell Imaging, by End User, Through 2029
Table 183: Global Market for Single-Cell Technologies, by Product, Through 2029
Table 184: Assay Kits Offered by 10X Genomics
Table 185: Global Market for Single-Cell Technologies Consumables, by Region, Through 2029
Table 186: Single-Cell Technologies Flow Cytometry Systems, by Company
Table 187: Single-Cell Technologies NGS Systems, by Company
Table 188: Single-Cell Technologies PCR Systems, by Company
Table 189: Single-Cell Technologies Mass Spectrophotometers, by Company
Table 190: Single-Cell Technologies Microscopes, by Company
Table 191: Global Market for Single-Cell Technologies Instruments, by Region, Through 2029
Table 192: Global Market for Single-Cell Technologies, by Cell Type, Through 2029
Table 193: Global Market for Single-Cell Technologies in the Human Cells Segment, by Region, Through 2029
Table 194: Global Market for Single-Cell Technologies in the Animal Cells Segment, by Region, Through 2029
Table 195: Global Market for Single-Cell Technologies in the Microbial Cells Segment, by Region, Through 2029
Table 196: Global Market for Single-Cell Technologies, by Technique, Through 2029
Table 197: Global Market for Flow Cytometry in Single-Cell Technologies, by Region, Through 2029
Table 198: Global Market for Next-Generation Sequencing in Single-Cell Technologies, by Region, Through 2029
Table 199: Global Market for Polymerase Chain Reaction in Single-Cell Technologies, by Region, Through 2029
Table 200: Global Market for Microscopy in Single-Cell Technologies, by Region, Through 2029
Table 201: Global Market for Mass Spectrometry in Single-Cell Technologies, by Region, Through 2029
Table 202: Global Market for Other Techniques in Single-Cell Technologies, by Region, Through 2029
Table 203: Global Market for Single-Cell Technologies, by Application, Through 2029
Table 204: Global Market for Research Applications in Single-Cell Technologies, by Region, Through 2029
Table 205: Global Market for Medical Applications of Single-Cell Technologies, by Region, Through 2029
Table 206: Global Market for Single-Cell Technologies, by End User, Through 2029
Table 207: Global Market for Single-Cell Technologies in Research and Academic Laboratories, by Region, Through 2029
Table 208: Global Market for Single-Cell Technologies in Biotechnology and Pharmaceutical Companies, by Region, Through 2029
Table 209: Global Market for Single-Cell Technologies in Hospitals and Diagnostic Laboratories, by Region, Through 2029
Table 210: Stem Cell Banks and Registries Worldwide, by Country
Table 211: Global Market for Single-Cell Technologies in Cell Banks and IVF Centers, by Region, Through 2029
Table 212: Global Market for Single-Cell Technologies, by Region, Through 2029
List of Figures
Figure 1: Global Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 2: Global Market for CGT Tools and Reagents, by Region, 2021-2029
Figure 3: Market Dynamics of CGT Tools and Reagents
Figure 4: CGT Sector Investments, 2018-2023
Figure 5: CGT Sector Investments, by Deal Type, Q1 2024
Figure 6: Global Market Shares of CGT Tools and Reagents, by Product, 2024
Figure 7: Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
Figure 8: Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
Figure 9: Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
Figure 10: Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
Figure 11: Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
Figure 12: Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
Figure 13: Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
Figure 14: Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
Figure 15: Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
Figure 16: Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
Figure 17: Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
Figure 18: Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
Figure 19: Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
Figure 20: Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
Figure 21: Global Market Shares of CGT Tools and Reagents, by Application, 2024
Figure 22: Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
Figure 23: Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
Figure 24: Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
Figure 25: Global Market Shares of CGT Tools and Reagents, by End User, 2024
Figure 26: Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
Figure 27: Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
Figure 28: Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
Figure 29: Global Market Shares of CGT Tools and Reagents, by Region, 2024
Figure 30: North American Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 31: North American Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 32: North American Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 33: European Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 34: European Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 35: European Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 36: Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 37: Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 38: Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 39: RoW Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 40: RoW Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 41: RoW Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 42: How a Strong ESG Proposition Benefits Businesses
Figure 43: Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
Figure 44: Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
Figure 45: Market Dynamics of Cell Therapy Biomanufacturing
Figure 46: Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
Figure 47: Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
Figure 48: Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
Figure 49: North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 50: European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 51: Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 52: RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 53: Global Market for Gene Synthesis, by Services, 2020-2028
Figure 54: Market Dynamics of Gene Synthesis
Figure 55: Global Market Shares for Gene Synthesis, by Method, 2022
Figure 56: Global Market Shares for Gene Synthesis, by Services, 2022
Figure 57: Global Market Shares for Gene Synthesis, by Application, 2022
Figure 58: Global Market Shares for Gene Synthesis, by End User, 2022
Figure 59: Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
Figure 60: Market Dynamics of Global Automated and Closed Cell Therapy Market
Figure 61: Global Market Shares of Automated and Closed Cell Therapy, by Automation Type, 2023
Figure 62: Global Market for Semi-Automated Cell Therapy, by Region, 2021-2029
Figure 63: Global Market for Fully Automated Cell Therapy, by Region, 2021-2029
Figure 64: Global Market Shares of Automated and Closed Cell Therapy, by Cell Type, 2023
Figure 65: Global Market for Automated and Closed CAR-T Cell Therapy, 2021-2029
Figure 66: Global Market for Automated and Closed CAR-T Cell Therapy, by Region, 2021-2029
Figure 67: Global Market for Automated and Closed Stem Cell Therapy, 2021-2029
Figure 68: Global Market for Automated and Closed Stem Cell Therapy, by Region, 2021-2029
Figure 69: Global Market for Automated and Closed Other Cell Therapies, 2021-2029
Figure 70: Global Market for Automated and Closed Other Cell Therapies, by Region, 2021-2029
Figure 71: Global Market Shares of Automated and Closed Cell Therapy, by Application, 2023
Figure 72: Global Market for Clinical Automated and Closed Cell Therapy, 2021-2029
Figure 73: Global Market for Commercial Automated and Closed Cell Therapy, 2021-2029
Figure 74: Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
Figure 75: Global Market for Automated and Closed Cell Therapy, by Region, 2021-2029
Figure 76: North American Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 77: U.S. Market for Automated and Closed Cell Therapy, 2021-2029
Figure 78: Canadian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 79: Mexican Market for Automated and Closed Cell Therapy, 2021-2029
Figure 80: European Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 81: German Market for Automated and Closed Cell Therapy, 2021-2029
Figure 82: French Market for Automated and Closed Cell Therapy, 2021-2029
Figure 83: Italian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 84: Spanish Market for Automated and Closed Cell Therapy, 2021-2029
Figure 85: U.K. Market for Automated and Closed Cell Therapy, 2021-2029
Figure 86: Rest of European Market for Automated and Closed Cell Therapy, 2021-2029
Figure 87: Asia-Pacific Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 88: Chinese Market for Automated and Closed Cell Therapy, 2021-2029
Figure 89: Japanese Market for Automated and Closed Cell Therapy, 2021-2029
Figure 90: Indian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 91: Australian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 92: South Korean Market for Automated and Closed Cell Therapy, 2021-2029
Figure 93: Rest of Asia-Pacific Market for Automated and Closed Cell Therapy, 2021-2029
Figure 94: Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
Figure 95: Cell and Gene Therapy Market Dynamics
Figure 96: Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
Figure 97: Global Market Shares of Cell and Gene Therapy, by Type of Therapy, 2022
Figure 98: Global Market for Cell Therapy, by Region, 2020-2028
Figure 99: Global Market for Gene-modified Cell Therapy, by Region, 2020-2028
Figure 100: Global Market for Gene Therapy, by Region, 2020-2028
Figure 101: Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2020-2028
Figure 102: Global Market Shares of Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2022
Figure 103: Global Market for AAV Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 104: Global Market for Retroviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 105: Global Market for Lentiviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 106: Global Market for Other Vectors Used in Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 107: Global Market for Cell and Gene Therapy, by Drug Product, 2020-2028
Figure 108: Global Market Shares of Cell and Gene Therapy, by Drug Product, 2022
Figure 109: Global Market for Zolgensma for Cell and Gene Therapy, 2020-2028
Figure 110: Global Market for Yescarta for Cell and Gene Therapy, 2020-2028
Figure 111: Global Market for Kymriah for Cell and Gene Therapy, 2020-2028
Figure 112: Global Market for Abecma for Cell and Gene Therapy, 2020-2028
Figure 113: Global Market for Maci for Cell and Gene Therapy, 2020-2028
Figure 114: Global Market for Tecartus for Cell and Gene Therapy, 2020-2028
Figure 115: Global Market for Epicel for Cell and Gene Therapy, 2020-2028
Figure 116: Global Market for Other Types of Drugs Used in Drugs Cell and Gene Therapy, 2020-2028
Figure 117: Global Market for Cell and Gene Therapy, by Application, 2020-2028
Figure 118: Global Market Shares of Cell and Gene Therapy, by Application, 2022
Figure 119: Global Market Cell and Gene Therapy for Oncology, by Region, 2020-2028
Figure 120: Global Market for Cell and Gene Therapy for Rare Diseases, by Region, 2020-2028
Figure 121: Global Market for Cell and Gene Therapy for Ophthalmology, by Region, 2020-2028
Figure 122: Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, 2020-2028
Figure 123: Global Market for Cell and Gene Therapy, by Region, 2020-2028
Figure 124: Global Market Shares of Cell and Gene Therapy, by Region, 2022
Figure 125: North American Market Shares of Cell and Gene Therapy, by Country, 2022
Figure 126: U.S. Market for Cell and Gene Therapy, 2020-2028
Figure 127: Canadian Market for Cell and Gene Therapy, 2020-2028
Figure 128: Mexican Market for Cell and Gene Therapy, 2020-2028
Figure 129: European Market Shares of Cell and Gene Therapy, by Country, 2022
Figure 130: German Market for Cell and Gene Therapy, 2020-2028
Figure 131: U.K. Market for Cell and Gene Therapy, 2020-2028
Figure 132: French Market for Cell and Gene Therapy, 2020-2028
Figure 133: Rest of European Market for Cell and Gene Therapy, 2020-2028
Figure 134: Asia-Pacific Market Shares of Cell and Gene Therapy, by Country, 2022
Figure 135: Japanese Market for Cell and Gene Therapy, 2020-2028
Figure 136: Chinese Market for Cell and Gene Therapy, 2020-2028
Figure 137: Australian Market for Cell and Gene Therapy, 2020-2028
Figure 138: Rest of Asia-Pacific Market for Cell and Gene Therapy, 2020-2028
Figure 139: RoW Market for Cell and Gene Therapy, 2020-2028
Figure 140: Global Market for Live Cell Imaging, by Region, 2021-2029
Figure 141: Market Dynamics of Global Live Cell Imaging Market
Figure 142: Total Stem Cell Research Funding by the National Institutes for Health, 2013-2025
Figure 143: Global Market Shares of Live Cell Imaging, by Components, 2023
Figure 144: Global Market Shares of Live Cell Imaging, by Technology, 2023
Figure 145: Global Market Shares of Live Cell Imaging, by End-user, 2023
Figure 146: Global Market Shares of Live Cell Imaging, by Region, 2023
Figure 147: North American Market Shares of Live Cell Imaging, by Country, 2023
Figure 148: North American Market for Live Cell Imaging, by Components, 2021-2029
Figure 149: North American Market for Live Cell Imaging, by Technology, 2021-2029
Figure 150: North American Market for Live Cell Imaging, by End User, 2021-2029
Figure 151: U.S. Market for Live Cell Imaging, 2021-2029
Figure 152: Canadian Market for Live Cell Imaging, 2021-2029
Figure 153: Mexican Market for Live Cell Imaging, 2021-2029
Figure 154: European Market Shares of Live Cell Imaging, by Country, 2023
Figure 155: European Market for Live Cell Imaging, by Components, 2021-2029
Figure 156: European Market for Live Cell Imaging, by Technology, 2021-2029
Figure 157: European Market for Live Cell Imaging, by End User, 2021-2029
Figure 158: German Market for Live Cell Imaging, 2021-2029
Figure 159: U.K. Market for Live Cell Imaging, 2021-2029
Figure 160: French Market for Live Cell Imaging, 2021-2029
Figure 161: Spanish Market for Live Cell Imaging, 2021-2029
Figure 162: Italian Market for Live Cell Imaging, 2021-2029
Figure 163: Rest of European Market for Live Cell Imaging, 2021-2029
Figure 164: Asia-Pacific Market Shares of Live Cell Imaging, by Country, 2023
Figure 165: Asia-Pacific Market for Live Cell Imaging, by Components, 2021-2029
Figure 166: Asia-Pacific Market for Live Cell Imaging, by Technology, 2021-2029
Figure 167: Asia-Pacific Market for Live Cell Imaging, by End User, 2021-2029
Figure 168: Chinese Market for Live Cell Imaging, 2021-2029
Figure 169: Japanese Market for Live Cell Imaging, 2021-2029
Figure 170: Indian Market for Live Cell Imaging, 2021-2029
Figure 171: South Korean Market for Live Cell Imaging, 2021-2029
Figure 172: Rest of Asia-Pacific Market for Live Cell Imaging, 2021-2029
Figure 173: Rest of the World Market for Live Cell Imaging, by Components, 2021-2029
Figure 174: Rest of the World Market for Live Cell Imaging, by Technology, 2021-2029
Figure 175: Rest of the World Market for Live Cell Imaging, by End User, 2021-2029
Figure 176: Global Market for Single-Cell Technologies, by Product, 2021-2029
Figure 177: Market Dynamics of Single-Cell Technologies
Figure 178: Estimated Numbers of All Cancer Cases, Males and Females (0 to 85+ Years), 2022-2050
Figure 179: Personalized Medicine: Growing Share in Total New Molecular Entities (NMEs), 2019-2022
Figure 180: Percentage of Deaths from NCDs in Asia-Pacific Countries, 2019
Figure 181: Global Market Shares of Single-Cell Technologies, by Product, 2023
Figure 182: Global Market Shares of Single-Cell Technologies, by Cell Type, 2023
Figure 183: Global Market Shares of Single-Cell Technologies, by Technique, 2023
Figure 184: Cost for Sequencing a Human Genome, November 2017-May 2022
Figure 185: Global Market Shares of Single-Cell Technologies, by Application, 2023
Figure 186: Global Market Shares of Single-Cell Technologies, by End User, 2023
Figure 187: Examples of Research and Academic Laboratories Utilizing Single-Cell Technologies
Figure 188: Global Market Shares of Single-Cell Technologies, by Region, 2023
Figure 189: U.S. NIH Funding for Genome Research, 2021-2023
Figure 190: North American Market for Single-Cell Technologies, 2021-2029
Figure 191: European Market for Single-Cell Technologies, 2021-2029
Figure 192: Asia-Pacific Market for Single-Cell Technologies, 2021-2029
Figure 193: Rest of the World Market for Single-Cell Technologies, 2021-2029
Figure 2: Global Market for CGT Tools and Reagents, by Region, 2021-2029
Figure 3: Market Dynamics of CGT Tools and Reagents
Figure 4: CGT Sector Investments, 2018-2023
Figure 5: CGT Sector Investments, by Deal Type, Q1 2024
Figure 6: Global Market Shares of CGT Tools and Reagents, by Product, 2024
Figure 7: Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
Figure 8: Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
Figure 9: Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
Figure 10: Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
Figure 11: Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
Figure 12: Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
Figure 13: Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
Figure 14: Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
Figure 15: Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
Figure 16: Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
Figure 17: Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
Figure 18: Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
Figure 19: Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
Figure 20: Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
Figure 21: Global Market Shares of CGT Tools and Reagents, by Application, 2024
Figure 22: Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
Figure 23: Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
Figure 24: Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
Figure 25: Global Market Shares of CGT Tools and Reagents, by End User, 2024
Figure 26: Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
Figure 27: Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
Figure 28: Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
Figure 29: Global Market Shares of CGT Tools and Reagents, by Region, 2024
Figure 30: North American Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 31: North American Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 32: North American Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 33: European Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 34: European Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 35: European Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 36: Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 37: Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 38: Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 39: RoW Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 40: RoW Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 41: RoW Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 42: How a Strong ESG Proposition Benefits Businesses
Figure 43: Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
Figure 44: Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
Figure 45: Market Dynamics of Cell Therapy Biomanufacturing
Figure 46: Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
Figure 47: Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
Figure 48: Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
Figure 49: North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 50: European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 51: Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 52: RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 53: Global Market for Gene Synthesis, by Services, 2020-2028
Figure 54: Market Dynamics of Gene Synthesis
Figure 55: Global Market Shares for Gene Synthesis, by Method, 2022
Figure 56: Global Market Shares for Gene Synthesis, by Services, 2022
Figure 57: Global Market Shares for Gene Synthesis, by Application, 2022
Figure 58: Global Market Shares for Gene Synthesis, by End User, 2022
Figure 59: Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
Figure 60: Market Dynamics of Global Automated and Closed Cell Therapy Market
Figure 61: Global Market Shares of Automated and Closed Cell Therapy, by Automation Type, 2023
Figure 62: Global Market for Semi-Automated Cell Therapy, by Region, 2021-2029
Figure 63: Global Market for Fully Automated Cell Therapy, by Region, 2021-2029
Figure 64: Global Market Shares of Automated and Closed Cell Therapy, by Cell Type, 2023
Figure 65: Global Market for Automated and Closed CAR-T Cell Therapy, 2021-2029
Figure 66: Global Market for Automated and Closed CAR-T Cell Therapy, by Region, 2021-2029
Figure 67: Global Market for Automated and Closed Stem Cell Therapy, 2021-2029
Figure 68: Global Market for Automated and Closed Stem Cell Therapy, by Region, 2021-2029
Figure 69: Global Market for Automated and Closed Other Cell Therapies, 2021-2029
Figure 70: Global Market for Automated and Closed Other Cell Therapies, by Region, 2021-2029
Figure 71: Global Market Shares of Automated and Closed Cell Therapy, by Application, 2023
Figure 72: Global Market for Clinical Automated and Closed Cell Therapy, 2021-2029
Figure 73: Global Market for Commercial Automated and Closed Cell Therapy, 2021-2029
Figure 74: Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
Figure 75: Global Market for Automated and Closed Cell Therapy, by Region, 2021-2029
Figure 76: North American Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 77: U.S. Market for Automated and Closed Cell Therapy, 2021-2029
Figure 78: Canadian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 79: Mexican Market for Automated and Closed Cell Therapy, 2021-2029
Figure 80: European Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 81: German Market for Automated and Closed Cell Therapy, 2021-2029
Figure 82: French Market for Automated and Closed Cell Therapy, 2021-2029
Figure 83: Italian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 84: Spanish Market for Automated and Closed Cell Therapy, 2021-2029
Figure 85: U.K. Market for Automated and Closed Cell Therapy, 2021-2029
Figure 86: Rest of European Market for Automated and Closed Cell Therapy, 2021-2029
Figure 87: Asia-Pacific Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 88: Chinese Market for Automated and Closed Cell Therapy, 2021-2029
Figure 89: Japanese Market for Automated and Closed Cell Therapy, 2021-2029
Figure 90: Indian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 91: Australian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 92: South Korean Market for Automated and Closed Cell Therapy, 2021-2029
Figure 93: Rest of Asia-Pacific Market for Automated and Closed Cell Therapy, 2021-2029
Figure 94: Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
Figure 95: Cell and Gene Therapy Market Dynamics
Figure 96: Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
Figure 97: Global Market Shares of Cell and Gene Therapy, by Type of Therapy, 2022
Figure 98: Global Market for Cell Therapy, by Region, 2020-2028
Figure 99: Global Market for Gene-modified Cell Therapy, by Region, 2020-2028
Figure 100: Global Market for Gene Therapy, by Region, 2020-2028
Figure 101: Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2020-2028
Figure 102: Global Market Shares of Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2022
Figure 103: Global Market for AAV Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 104: Global Market for Retroviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 105: Global Market for Lentiviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 106: Global Market for Other Vectors Used in Gene-modified Cell Therapy and Gene Therapy, 2020-2028
Figure 107: Global Market for Cell and Gene Therapy, by Drug Product, 2020-2028
Figure 108: Global Market Shares of Cell and Gene Therapy, by Drug Product, 2022
Figure 109: Global Market for Zolgensma for Cell and Gene Therapy, 2020-2028
Figure 110: Global Market for Yescarta for Cell and Gene Therapy, 2020-2028
Figure 111: Global Market for Kymriah for Cell and Gene Therapy, 2020-2028
Figure 112: Global Market for Abecma for Cell and Gene Therapy, 2020-2028
Figure 113: Global Market for Maci for Cell and Gene Therapy, 2020-2028
Figure 114: Global Market for Tecartus for Cell and Gene Therapy, 2020-2028
Figure 115: Global Market for Epicel for Cell and Gene Therapy, 2020-2028
Figure 116: Global Market for Other Types of Drugs Used in Drugs Cell and Gene Therapy, 2020-2028
Figure 117: Global Market for Cell and Gene Therapy, by Application, 2020-2028
Figure 118: Global Market Shares of Cell and Gene Therapy, by Application, 2022
Figure 119: Global Market Cell and Gene Therapy for Oncology, by Region, 2020-2028
Figure 120: Global Market for Cell and Gene Therapy for Rare Diseases, by Region, 2020-2028
Figure 121: Global Market for Cell and Gene Therapy for Ophthalmology, by Region, 2020-2028
Figure 122: Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, 2020-2028
Figure 123: Global Market for Cell and Gene Therapy, by Region, 2020-2028
Figure 124: Global Market Shares of Cell and Gene Therapy, by Region, 2022
Figure 125: North American Market Shares of Cell and Gene Therapy, by Country, 2022
Figure 126: U.S. Market for Cell and Gene Therapy, 2020-2028
Figure 127: Canadian Market for Cell and Gene Therapy, 2020-2028
Figure 128: Mexican Market for Cell and Gene Therapy, 2020-2028
Figure 129: European Market Shares of Cell and Gene Therapy, by Country, 2022
Figure 130: German Market for Cell and Gene Therapy, 2020-2028
Figure 131: U.K. Market for Cell and Gene Therapy, 2020-2028
Figure 132: French Market for Cell and Gene Therapy, 2020-2028
Figure 133: Rest of European Market for Cell and Gene Therapy, 2020-2028
Figure 134: Asia-Pacific Market Shares of Cell and Gene Therapy, by Country, 2022
Figure 135: Japanese Market for Cell and Gene Therapy, 2020-2028
Figure 136: Chinese Market for Cell and Gene Therapy, 2020-2028
Figure 137: Australian Market for Cell and Gene Therapy, 2020-2028
Figure 138: Rest of Asia-Pacific Market for Cell and Gene Therapy, 2020-2028
Figure 139: RoW Market for Cell and Gene Therapy, 2020-2028
Figure 140: Global Market for Live Cell Imaging, by Region, 2021-2029
Figure 141: Market Dynamics of Global Live Cell Imaging Market
Figure 142: Total Stem Cell Research Funding by the National Institutes for Health, 2013-2025
Figure 143: Global Market Shares of Live Cell Imaging, by Components, 2023
Figure 144: Global Market Shares of Live Cell Imaging, by Technology, 2023
Figure 145: Global Market Shares of Live Cell Imaging, by End-user, 2023
Figure 146: Global Market Shares of Live Cell Imaging, by Region, 2023
Figure 147: North American Market Shares of Live Cell Imaging, by Country, 2023
Figure 148: North American Market for Live Cell Imaging, by Components, 2021-2029
Figure 149: North American Market for Live Cell Imaging, by Technology, 2021-2029
Figure 150: North American Market for Live Cell Imaging, by End User, 2021-2029
Figure 151: U.S. Market for Live Cell Imaging, 2021-2029
Figure 152: Canadian Market for Live Cell Imaging, 2021-2029
Figure 153: Mexican Market for Live Cell Imaging, 2021-2029
Figure 154: European Market Shares of Live Cell Imaging, by Country, 2023
Figure 155: European Market for Live Cell Imaging, by Components, 2021-2029
Figure 156: European Market for Live Cell Imaging, by Technology, 2021-2029
Figure 157: European Market for Live Cell Imaging, by End User, 2021-2029
Figure 158: German Market for Live Cell Imaging, 2021-2029
Figure 159: U.K. Market for Live Cell Imaging, 2021-2029
Figure 160: French Market for Live Cell Imaging, 2021-2029
Figure 161: Spanish Market for Live Cell Imaging, 2021-2029
Figure 162: Italian Market for Live Cell Imaging, 2021-2029
Figure 163: Rest of European Market for Live Cell Imaging, 2021-2029
Figure 164: Asia-Pacific Market Shares of Live Cell Imaging, by Country, 2023
Figure 165: Asia-Pacific Market for Live Cell Imaging, by Components, 2021-2029
Figure 166: Asia-Pacific Market for Live Cell Imaging, by Technology, 2021-2029
Figure 167: Asia-Pacific Market for Live Cell Imaging, by End User, 2021-2029
Figure 168: Chinese Market for Live Cell Imaging, 2021-2029
Figure 169: Japanese Market for Live Cell Imaging, 2021-2029
Figure 170: Indian Market for Live Cell Imaging, 2021-2029
Figure 171: South Korean Market for Live Cell Imaging, 2021-2029
Figure 172: Rest of Asia-Pacific Market for Live Cell Imaging, 2021-2029
Figure 173: Rest of the World Market for Live Cell Imaging, by Components, 2021-2029
Figure 174: Rest of the World Market for Live Cell Imaging, by Technology, 2021-2029
Figure 175: Rest of the World Market for Live Cell Imaging, by End User, 2021-2029
Figure 176: Global Market for Single-Cell Technologies, by Product, 2021-2029
Figure 177: Market Dynamics of Single-Cell Technologies
Figure 178: Estimated Numbers of All Cancer Cases, Males and Females (0 to 85+ Years), 2022-2050
Figure 179: Personalized Medicine: Growing Share in Total New Molecular Entities (NMEs), 2019-2022
Figure 180: Percentage of Deaths from NCDs in Asia-Pacific Countries, 2019
Figure 181: Global Market Shares of Single-Cell Technologies, by Product, 2023
Figure 182: Global Market Shares of Single-Cell Technologies, by Cell Type, 2023
Figure 183: Global Market Shares of Single-Cell Technologies, by Technique, 2023
Figure 184: Cost for Sequencing a Human Genome, November 2017-May 2022
Figure 185: Global Market Shares of Single-Cell Technologies, by Application, 2023
Figure 186: Global Market Shares of Single-Cell Technologies, by End User, 2023
Figure 187: Examples of Research and Academic Laboratories Utilizing Single-Cell Technologies
Figure 188: Global Market Shares of Single-Cell Technologies, by Region, 2023
Figure 189: U.S. NIH Funding for Genome Research, 2021-2023
Figure 190: North American Market for Single-Cell Technologies, 2021-2029
Figure 191: European Market for Single-Cell Technologies, 2021-2029
Figure 192: Asia-Pacific Market for Single-Cell Technologies, 2021-2029
Figure 193: Rest of the World Market for Single-Cell Technologies, 2021-2029
